Literature DB >> 16440831

46 XX male syndrome: a case report.

F Yencilek1, C Baykal.   

Abstract

INTRODUCTION: 46 XX male syndrome (de la Chapelle syndrome) is a rarely seen genetic disorder causing male infertility. It is generally a result of unequal crossing over between X and Y chromosomes. CASE REPORT: A 26-year-old infertile male was referred to the Urology Department. He had normal external male genital phenotype and secondary sex characters. No gynecomastia was noted. At physical examination soft and atrophic testes were palpated. Laboratory analysis and testis biopsies indicated nonobstructive azospermia. Chromosomal analysis showed 46 XX karyotype.
CONCLUSION: In the literature, there are various phenotypic properties of 46 XX male patients. Thus, translocation of the sex determining region (SRY) the gene probably cannot be the only reason for XX male syndrome. There might be some other abnormalities leading to de la Chapelle syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16440831

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  4 in total

Review 1.  Klinefelter syndrome and other sex chromosomal aneuploidies.

Authors:  Jeannie Visootsak; John M Graham
Journal:  Orphanet J Rare Dis       Date:  2006-10-24       Impact factor: 4.123

2.  Cytogenetic Investigation in a Group of Ten Infertile Men with Non-Obstructive Azoospermia: First Algerian 46, XX Syndrome.

Authors:  Meriem Baziz; Zohra Hamouli-Said; Ilham Ratbi; Mohamed Habel; Soukaina Guaoua; Aziza Sbiti; Abdelaziz Sefiani
Journal:  Iran J Public Health       Date:  2016-06       Impact factor: 1.429

3.  46XX Testicular Disorder of Sex Development.

Authors:  Krishna Chaitanya Mantravadi; Durga Gedela Rao
Journal:  J Hum Reprod Sci       Date:  2021-12-31

Review 4.  46 XX karyotype during male fertility evaluation; case series and literature review.

Authors:  Ahmad Majzoub; Mohamed Arafa; Christopher Starks; Haitham Elbardisi; Sami Al Said; Edmund Sabanegh
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.